Discover 1,289 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Columbus hosts a variety of active clinical studies, including for conditions such as diabetes, asthma, and cardiovascular diseases. The city's prominent healthcare institutions are recruiting participants, both as healthy volunteers seeking paid research opportunities and individuals in need of trials for specific conditions, offering access to new and innovative treatments and therapies.
Filter
2
Filter results
Results: 1,289
SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
for
Brain Metastases, HR+ Metastatic Breast Cancer
Location: Columbus OH
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT04923542
Phase1, Phase2, Recruiting
Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases
for
Non Small Cell Lung Cancer, NSCLC, KRAS G12C
Location: Columbus OH, Charlottesville VA, Richmond VA
Sponsor: Ryan Gentzler, MD
Sex: All
Age: 18+
Code: NCT06248606
Phase2, Recruiting
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Location: Columbus OH, Richmond VA, Derby CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06465316
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
for
Breast Cancer
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: Female
Age: 18+
Code: NCT04022616
Recruiting
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
for
Advanced Malignant Solid Neoplasm,
Location: Columbus OH, Bethesda MD, New York NY, Mineola NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05687136
Phase1, Recruiting
Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Columbus OH, Richmond VA, Minneapolis MN
Sponsor: Yazeed Sawalha
Sex: All
Age: 18+
Code: NCT06536049
Phase1, Phase2, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Columbus OH, Ypsilanti MI, Canton MI, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase2, Recruiting
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
for
Nodular Lymphocyte Predominant B-Cell Lymphoma,
Location: Columbus OH, Cincinnati OH, West Chester OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05886036
Phase2, Recruiting
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
for
Triple Negative Locally Advanced Non-resectable Breast Cancer,
Location: Columbus OH, Toronto, Nashville TN, Boston MA,
Sponsor: Marengo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06827613
Phase1, Phase2, Recruiting
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Columbus OH, Indianapolis IN, Chicago IL,
Sponsor: NRG Oncology
Sex: Female
Age: 18+
Code: NCT06388018
Phase2, Recruiting
CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma
for
B-Cell Non-Hodgkin Lymphoma-Recurrent,
Location: Columbus OH
Sponsor: Nathan Denlinger
Sex: All
Age: 18+
Code: NCT06209619
Phase1, Recruiting
Informing Oral Nicotine Pouch Regulations to Promote Public Health
for
Tobacco-Related Carcinoma
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 21+
Code: NCT06315881
Phase2, Recruiting
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
for
Advanced Malignant Solid Neoplasm,
Location: Columbus OH, Lexington KY, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06311214
Phase2, Recruiting
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
for
NSCLC, Stage I
Location: Columbus OH, Indianapolis IN, Charlottesville VA,
Sponsor: Greg Durm, MD
Sex: All
Age: 18+
Code: NCT04317534
Phase2, Recruiting
Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction
for
Blasts More Than 5 Percent of Bone Marrow Nucleated Cells,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT04049539
Phase1, Phase2, Recruiting
Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Columbus OH
Sponsor: Kerry Rogers
Sex: All
Age: 18+
Code: NCT06466122
Phase2, Recruiting
Weighted Blanket Use to Reduce Anxiety in Oncology Patients
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06089408
Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial